Track-and-Trace Deal Chances Trending Up
This article was originally published in The Pink Sheet Daily
Executive Summary
GPhA head says Congress remains committed to passing its preferred lot-level tracking proposal and leadership in both congressional chambers will find a vehicle, possibly to get it passed during the upcoming lame-duck session.
You may also be interested in...
Track-and-Trace Law: Push Begins For 2015 Exchange Standards
FDA has a tight deadline to finalize guidance on transaction information.
Track-and-Trace Deal’s Failure Leaves California In Control Of Agenda
Industry groups will continue to search for legislative vehicles to move a national standard that would preempt state laws; near-term, though, manufacturers and distributors must prepare for California pedigree law.
Track And Trace: Substandard System Is Not Better Than Nothing, FDA Says
CDER Director Janet Woodcock says an industry coalition’s proposal would not meet FDA’s drug tracking needs and is not worth the cost of implementing, even though industry says FDA’s preference is cost-prohibitive.